Quick Links

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.


PER Pulse™ Recaps
for the Working Group to Personalize Multidisciplinary Care in Patients with Lung Cancer: Updates and Evolving Concepts for Nurses symposium focus on targeted agents, toxicity management, and liquid biopsies for patients with lung cancer that were discussed by the expert faculty at this program.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca.

Community Practice Connections™: Working Group to Personalize Multidisciplinary Care in Patients with Lung Cancer: Updates and Evolving Concepts for Nurses

Release Date: June 22, 2016
Expiration Date: June 22, 2017
Media: Internet - based

Activity Overview

This educational activity is geared toward practical applications of treatment strategies in the clinic. Key data related to a live symposium held at a recent oncology nursing meeting, that focused on the treatment of lung cancer, are now available as downloadable slides. Participants can test their knowledge through interactive clinical vignettes and view short video clips from the faculty to gain an expert perspective on clinical scenarios they face in the care of their patients with lung cancer. Due to the overwhelming amount of new information concerning the treatment of lung cancer with targeted agents, combined with evolving methodologies in using molecular profiling tools and techniques to guide therapy, educational activities that showcase expert discussions—combined with sharing of best practices—are key for the practitioners tasked with managing these challenging scenarios.

CME/CE Activity Table of Contents

  • Targeting Epidermal Growth Factor Receptor Mutations in Non-Small-Cell Lung Cancer

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.

Target Audience

This educational program is directed toward nurses and other health care professionals with an interest in the treatment of lung cancers.

Educational Objectives

At the conclusion of this activity, you should be better prepared to:
  • Discuss emerging methods to personalize care in multiple lines of care for patients with EGFR-mutated advanced non–small cell lung cancer (NSCLC)
  • Explain key tumor information and testing methods by which this information can be obtained in patients with advanced NSCLC and EGFR-TKI resistance
  • Describe current and emerging evidence concerning the use of EGFR-TKIs to manage patients with NSCLC through multiple lines of care
  • Evaluate the role of the nurse to maximize outcomes in EGFR-mutated advanced NSCLC via optimization of efficacy via appropriate molecular marker testing, proactive management of predictable treatment-related side effects, and facilitation of recruitment for clinical trials

Faculty, Staff, and Planners' Disclosures

Program Co-Chairs

Benjamin Levy, MD
Assistant Professor, Icahn School of Medicine
Medical Director, Thoracic Oncology Program, Mount Sinai Health Systems
Associate Director, Cancer Clinical Trials Office, Mount Sinai Hospital
Mount Sinai Hospital
New York, NY
Disclosure: Consultant: Celgene, AstraZeneca, Lilly, Genentech, Pfizer, Merck; Speaker’s Bureau: Lilly, Genentech.

Karen Lee, MSN, FNP-BC
Mount Sinai Hospital
New York, NY
Disclosure: Consultant: Pfizer; Speaker’s Bureau: Pfizer, Bristol-Meyers Squibb.


Laura Brennan FNP-C, AOCNP
Division of Hematology & Oncology
UC Davis Medical Center
Sacramento, CA
Disclosure: No relevant financial relationships with commercial interests.

Jonathan Riess, MD, MS
Assistant Professor of Medicine
Division of Hematology Oncology
UC Davis Comprehensive Cancer Center
Sacramento, CA
Disclosure: Grant/Research Support: Merck, Novartis, Millennium; Consultant: Celgene, Ariad, Clovis.

The staff of Physicians' Education Resource®, LLC, have no relevant financial relationships with commercial interests.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians' Education Resource®, LLC, (PER®) to ensure fair balance, independence, objectivity, and scientific rigor in all of our CME/CE activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Become a Member

Forgot Password?
Calendar of Events
Filter By